David C Whitcomb MD

Summary

• Professor David C. Whitcomb MD, PhD is a pioneer in using mathematics, genetics, neurosciences, immunology, epidemiology, and clinical sciences to study complex inflammatory disorders and cancer risks, with a focus on the pancreas (i.e. pancreatitis, pancreatic cancer and diabetes mellitus) and gastrointestinal disorders. He served as Chief of the Division of Gastroenterology, Hepatology and Nutrition at the University of Pittsburgh from 1999 to 2016, building it into a Top 5 ranked program by US News & World Report. He founded PancreasFest, an annual international translational research meeting that became the world’s leading pancreatic research conference for over two decades. Professor Whitcomb has published over 400 papers, reviews, and book chapters, with >40,000 citations, an h-index of >100, and an i10-index of >300.
  
  Professor Whitcomb completed an MS and a PhD in Physiology and received his MD, all from The Ohio State University. This was followed by postdoctoral training at Duke University, including internal medicine residency and a gastroenterology fellowship. He joined the University of Pittsburgh and UPMC as a physician-scientist in 1991, eventually holding the Giant Eagle Foundation Professor of Cancer Genetics endowed chair, and served as Professor of Medicine, Professor of Cell Biology & Molecular Physiology, and Professor of Human Genetics until 2022.
  
  Professor Whitcomb is currently Adjunct Professor of Biomedical Engineering at Carnegie Mellon University in Pittsburgh, where he teaches precision medicine, and Adjunct Professor of Gastroenterology, Christian Medical College, Vellore, India. As co-founder of Ariel Precision Medicine Inc. and SMART-MD Publishing LLC, he continues to advance precision medicine in pancreatic diseases, focusing on genetic risk stratification, personalized therapies, drug development, clinical trials, and clinical decision support systems.